Xeris Biopharma Holdings, Inc.·4

Feb 25, 6:03 PM ET

Nguyen Anh Tu 4

4 · Xeris Biopharma Holdings, Inc. · Filed Feb 25, 2026

Insider Transaction Report

Form 4
Period: 2026-02-24
Nguyen Anh Tu
See Remarks
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-02-24$6.88/sh29,300$201,584395,023 total
Holdings
  • Common Stock

    [F2]
    (indirect: By IRA)
    3,710
  • Common Stock

    [F2]
    (indirect: By Children)
    3,501
Footnotes (2)
  • [F1]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of February 24, 2026.
  • [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Signature
/s/ Beth Hecht, Attorney-in-Fact|2026-02-25

Documents

1 file
  • 4
    wk-form4_1772060591.xmlPrimary

    FORM 4